Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Genome Research|March 9, 2019
Experimental and pan-cancer genome analyses reveal widespread contribution of acrylamide exposure to carcinogenesis in humansMaria Zhivagui, Alvin W T Ng, Maude Ardin, et al.
Genome Research|July 26, 2017
Genome-scale mutational signatures of aflatoxin in cells, mice, and human tumorsMi Ni Huang, Willie Yu, Wei Wei Teoh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 16, 2025
Unravelling the tumor microenvironment and PD-L1 expression across tissue type in high-grade serous ovarian cancer in the NeoPembrOV/GINECO phase II randomized trialLaetitia Collet, Maude Ardin, David Venet, et al.
Plos One|May 12, 2015
Revealing the Molecular Portrait of Triple Negative Breast Tumors in an Understudied Population through Omics Analysis of Formalin-Fixed and Paraffin-Embedded TissuesFelipe Vaca-Paniagua, Rosa María Alvarez-Gomez, Hector Aquiles Maldonado-Martínez, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 19, 2015
Low-Coverage Exome Sequencing Screen in Formalin-Fixed Paraffin-Embedded Tumors Reveals Evidence of Exposure to Carcinogenic Aristolochic AcidXavier Castells, Sandra Karanović, Maude Ardin, et al.
The Journal of Experimental Medicine|April 2, 2024
NF-κB subunits RelA and c-Rel selectively control CD4+ T cell function in multiple sclerosis and cancerGuilhem Lalle, Raphaëlle Lautraite, Khaled Bouherrou, et al.
Nature Communications|July 16, 2024
Immunomic longitudinal profiling of the NeoPembrOv trial identifies drivers of immunoresistance in high-grade ovarian carcinomaOlivia Le Saux, Maude Ardin, Justine Berthet, et al.
ESMO Open|April 12, 2018
Relevance of a molecular tumour board (MTB) for patients' enrolment in clinical trials: experience of the Institut CurieClémence Basse, Claire Morel, Marie Alt, et al.
Nature Aging|December 28, 2024
A ganglioside-based immune checkpoint enables senescent cells to evade immunosurveillance during agingCharlène Iltis, Iryna Moskalevska, Antoine Debiesse, et al.
Nature Communications|March 15, 2018
Integrative genomic profiling of large-cell neuroendocrine carcinomas reveals distinct subtypes of high-grade neuroendocrine lung tumorsJulie George, Vonn Walter, Martin Peifer, et al.
Pageof 3